Chris Russo, Katerina Naydenova and Greg McMullan discuss the latest developments in the field of cryo-EM with Paul Brackley of the Cambridge Independent. “Based on this research, several companies and research groups are now working to make this technology widely available,

This Nature opinion piece recounts the dramatic impact of the pivotal 1975 paper by Köhler–Milstein on biomedical and, specifically, immunological research, which was propelled by scientific developments that occurred around the time the paper appeared. It also chronicles the research on monoclonal antibodies over the years all the way to Greg Winter’s research,

In conversation with the FEBS Journal, Greg discusses his early motivations, monoclonal antibody therapy research, life after the Nobel prize, and balancing entrepreneurship with science. He also lets in on a secret childhood fantasy, “As a boy I fancied being the captain of tramp steamer plying the South Pacific…”. 

Simon Crompton of The Times interviews Madeline about her early experience when growing mini brains in the lab and the journey towards insights into human brain development and what fundamentally sets us apart from animals (story behind paywall). More…

LMB’s newly recruited Group Leader weighs in on various aspects of Alzheimer’s Disease, from the clinical implications of deciphering Tau filaments in brains of people suffering from neurodegenerative diseases, to designing precise drugs. More…

This year’s Science and Technology Awards, run by Cambridge’s weekly newspaper, feature Benjamin Falcon from Neurobiology Division and Julius Fredens from Protein and Nucleic Acid Division as finalists. The ‘Researcher of the Year’ winner, out of a shortlist of six, will be announced at an awards ceremony at the Bradfield Centre.

And why does it matter? BBC writes about the role circadian rhythms plays in how our bodies respond to injuries, infections and healing, including work by John O’Neill’s group on tissue repair damage and biological time. More…

How are mini brains revolutionising neuroscience? FT’s annual scientific feature series visits the LMB and Madeline’s lab to trace the rapid development in the field since 2011 when Madeline pioneered the field of cerebral organoids and insights into mechanisms of some diseases.

The Economist draws on the evolution of the first cerebral organoids in Madeline Lancaster’s lab in 2013 to today’s research on electrical impulses from these mini brains. It discusses the fast pace of development in this scientific field and poses future research questions. 

Roger Highfield, Science Director of the Science Museum Group and a member of the Medical Research Council, writes about Jason and his team’s work at the LMB focusing on “turbocharging the ribosome”. Jason explains the process behind evolving new ribosomes and it marks a revolution in our ability to evolve,